单次卵巢内注射干细胞与血小板分泌因子可减轻小鼠模型中的年龄相关卵巢不孕
研究在模拟年轻、高龄产妇和绝经三个生理阶段的小鼠模型中,比较单次卵巢内注射生理盐水、活化富血小板血浆或骨髓来源干细胞联合活化富血小板血浆的效果。结果显示联合治疗促进卵泡激活与发育,改善老年小鼠卵母细胞数量质量及早期胚胎发育,效果优于单用富血小板血浆,但作者指出仍需人卵巢样本研究。
要点
- 单次卵巢内注射干细胞联合活化富血小板血浆促进各年龄段小鼠卵泡激活与发育。
- 联合治疗改善老年小鼠卵母细胞数量与质量,支持早期胚胎发育至囊胚阶段。
- 疗效与线粒体质量改善、线粒体DNA拷贝数增加及氧化损伤和凋亡减少相关。
核心结论
- 骨髓来源干细胞联合活化富血小板血浆是有前景的治疗,可能改善年龄相关不孕女性的生殖结局,效果超过单用富血小板血浆的修复作用。
- 作者指出仍需在人卵巢样本中进一步研究,但干细胞因子的自体来源、非侵入性动员、与富血小板血浆联合及局部给药途径提示该治疗可能对未来临床实践有效且安全。
研究设计与样本
- 研究在模拟女性生殖生活三个生理阶段(年轻、高龄产妇和绝经)的衰老小鼠模型中进行控制性卵巢刺激,每组12只动物。
- 雌性小鼠随机接受单次卵巢内注射(每侧卵巢10 μL)生理盐水、活化富血小板血浆或干细胞联合活化富血小板血浆。
- 注射7天后进行刺激、自然交配并处死,取卵巢做组织学评估和分子分析,取输卵管评估卵母细胞成熟和早期胚胎发育。
主要发现
- 单次卵巢内注射干细胞联合活化富血小板血浆促进年轻、高龄产妇和老年小鼠的卵泡激活与发育。
- 联合治疗通过提高排卵成熟卵母细胞的数量和质量、支持所有评估年龄段早期胚胎发育至囊胚阶段,恢复老年小鼠生育力。
- 这些生育结局与线粒体质量、治疗增加的线粒体DNA拷贝数以及减少的氧化损伤和凋亡正相关。
- 功能蛋白质组学分析揭示了涉及卵母细胞成熟与质量、线粒体功能和卵巢间质恢复的分子机制。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者指出仍需在人卵巢样本中进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Systemic administration of soluble factors from bone marrow-derived stem cells combined with activated platelet-rich plasma (SC-PRP) restored ovarian function, mediated through paracrine signaling, in murine models of chemotherapy-induced ovarian damage and human tissue from poor responder patients. However, the effects against age-related infertility and the efficacy of local administration have not been evaluated yet. OBJECTIVE: This study aimed to assess whether a single intraovarian dose of stem cells combined with activated platelet-rich plasma can recover ovarian function, oocyte quality, and developmental competence in older mice. STUDY DESIGN: The effects of stem cells combined with activated platelet-rich plasma against age-related infertility were assessed following controlled ovarian stimulation in an aging murine model reproducing 3 physiological stages of women's reproductive life, namely young, advanced maternal age, and menopausal (n=12 animals per group). Female mice were randomized to receive a single intraovarian injection (10 μL/ovary) of either saline, activated platelet-rich plasma, or stem cells combined with activated platelet-rich plasma. Seven days later, the mice were stimulated, naturally mated, and sacrificed to harvest their ovaries for histologic assessment and molecular analysis and their oviducts to evaluate oocyte maturation and to assess early embryo development. RESULTS: A single intraovarian injection of stem cells combined with activated platelet-rich plasma promoted follicle activation and development in young, advanced maternal age, and old mice. Furthermore, stem cells combined with activated platelet-rich plasma rescued fertility in older mice by enhancing the quantity and quality of ovulated mature oocytes and supporting early embryo development to the blastocyst stage in all the evaluated ages. These fertility outcomes were positively associated with mitochondrial quality, treatment-increased mitochondrial DNA copy numbers, and reduced oxidative damage and apoptosis. Finally, the effects observed by histologic analysis were supported at the proteomic level. Functional proteomic analyses revealed molecular mechanisms involved in oocyte maturation and quality, mitochondrial function, and recovery of the ovarian stroma. CONCLUSION: Bone marrow-derived stem cells combined with activated platelet-rich plasma is a promising treatment with the potential to improve the reproductive outcomes of women with age-related infertility, exceeding the restorative effects of platelet-rich plasma alone. Although further research in human ovarian samples is still required, the autologous nature of stem cell factors collected by noninvasive mobilization, their combination with platelet-rich plasma, and the local administration route suggest that stem cells combined with activated platelet-rich plasma treatment could be a potentially effective and safe application for future clinical practice.
引用
- Marchante M, Buigues A, Ramirez-Martin N, et al. Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model. Am J Obstet Gynecol. 2023. PMID: 36706857. doi:10.1016/j.ajog.2023.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。